Found: 9
Select item for more details and to access through your institution.
The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies.
- Published in:
- Human Reproduction Update, 2011, v. 17, n. 6, p. 791, doi. 10.1093/humupd/dmr030
- By:
- Publication type:
- Article
The Development of Subcutaneous Sarcomas in Rodents Exposed to Peroxisome Proliferators Agonists: Hypothetical Mechanisms of Action and De-Risking Attitude.
- Published in:
- Toxicologic Pathology, 2012, v. 40, n. 5, p. 810, doi. 10.1177/0192623312441406
- By:
- Publication type:
- Article
The PPARα Agonists Fenofibrate and CP-778875 Cause Increased β-Oxidation, Leading to Oxidative Injury in Skeletal and Cardiac Muscle in the Rat.
- Published in:
- Toxicologic Pathology, 2012, v. 40, n. 3, p. 435, doi. 10.1177/0192623311431945
- By:
- Publication type:
- Article
Using Laser Scanning Cytometry to Measure PPAR-Mediated Peroxisome Proliferation and β Oxidation.
- Published in:
- Toxicologic Pathology, 2005, v. 33, n. 1, p. 86, doi. 10.1080/01926230590881817
- By:
- Publication type:
- Article
The in vivo rat skin photomicronucleus assay: phototoxicity and photogenotoxicity evaluation of six fluoroquinolones.
- Published in:
- Mutagenesis, 2012, v. 27, n. 6, p. 721, doi. 10.1093/mutage/ges038
- By:
- Publication type:
- Article
Development and characterization of an in vivo skin photomicronucleus assay in rats.
- Published in:
- Mutagenesis, 2010, v. 25, n. 4, p. 407, doi. 10.1093/mutage/geq023
- By:
- Publication type:
- Article
International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 5, p. 723, doi. 10.1111/cts.13480
- By:
- Publication type:
- Article
Coordinated Expression of Multidrug Resistance-Associated Proteins (Mrps) in Mouse Liver during Toxicant-Induced Injury.
- Published in:
- Toxicological Sciences, 2006, v. 89, n. 2, p. 370, doi. 10.1093/toxsci/kfi332
- By:
- Publication type:
- Article
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 681, p. 1, doi. 10.1126/scitranslmed.abq5241
- By:
- Publication type:
- Article